Company newsroom
Protalix BioTherapeutics, Inc.
NYSE AMERICAN:PLX
2 releases
Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics Reports Third Quarter 2026 Financial and Business Results
Company to host conference call and webcast today at 8:00 a.m. ET Total revenues increased by $32.0 million year to date to $75.6 million, from $43.6…